2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial
Edelman E, Dziura J, Deng Y, DePhilippis D, Fucito L, Ferguson T, Bedimo R, Brown S, Marconi V, Goetz M, Rodriguez-Barradas M, Simberkoff M, Molina P, Weintrob A, Maisto S, Paris M, Justice A, Bryant K, Fiellin D. Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial. Contemporary Clinical Trials 2023, 131: 107242. PMID: 37230168, PMCID: PMC10460633, DOI: 10.1016/j.cct.2023.107242.Peer-Reviewed Original ResearchMeSH KeywordsAlcohol DrinkingCohort StudiesCOVID-19HIV InfectionsHumansPandemicsRandomized Controlled Trials as TopicConceptsUnhealthy alcohol useLong-term abstinenceAlcohol useContingency managementAlcohol consumptionFormal alcohol treatmentShort-term abstinenceMotivational enhancement therapyGOV IDENTIFIERSecondary outcomesWeek 24Primary outcomeWeek 12Preliminary efficacyTreatment trialsPhysician managementEfficacy trialsMedical conditionsAlcohol treatmentExploratory outcomesEnhancement therapyAbstinenceTrialsCareHealthy activities
2021
Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial
Rojewski AM, Fucito LM, Baker NL, Palmer AM, Foster MG, Warren GW, Bernstein SL, Toll BA. Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial. BMJ Open 2021, 11: e051226. PMID: 34187835, PMCID: PMC8245459, DOI: 10.1136/bmjopen-2021-051226.Peer-Reviewed Original ResearchMeSH KeywordsHumansMotivationNeoplasmsRandomized Controlled Trials as TopicSmokingSmoking CessationTobacco Use Cessation DevicesConceptsSmoking abstinenceSelf-reported smoking abstinenceCancer-specific mortalityNicotine replacement therapyTime of surgeryDay of surgerySmoking cessation treatmentCancer treatment toxicitiesSouth Carolina Institutional Review BoardEffect of CMBreath carbon monoxideContingency management interventionCO breath testInstitutional review boardSubstantial health risksOperable cancerContinued smokingPeer-reviewed journalsPreoperative periodStandard careSurgical complicationsTreatment toxicitySecondary malignanciesCessation treatmentReplacement therapy
2015
Interactive and Indirect Effects of Anxiety and Negative Urgency on Alcohol‐Related Problems
Menary KR, Corbin WR, Leeman RF, Fucito LM, Toll BA, DeMartini K, O'Malley SS. Interactive and Indirect Effects of Anxiety and Negative Urgency on Alcohol‐Related Problems. Alcohol Clinical And Experimental Research 2015, 39: 1267-1274. PMID: 26031346, PMCID: PMC4490982, DOI: 10.1111/acer.12762.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PsychologicalAlcohol-Related DisordersAnxietyCross-Sectional StudiesFemaleHumansMaleMotivationRandomized Controlled Trials as TopicYoung AdultConceptsNegative urgencyAlcohol problemsPotential moderatorsCoping-related drinking motivesDependence symptomsPrevention/intervention effortsNegative emotional statesIndirect effectsInteractive effectsAlcohol-related problemsCurrent cross-sectional studyAlcohol use disorderNegative affectDrinking motivesEmotional statesDrinking sampleModeration hypothesisIntervention effortsDirect interactive effectsAnxietyYoung adultsUse disordersLongitudinal dataModeratorPositive association
2014
Predictors of Abstinence from Heavy Drinking During Treatment in COMBINE and External Validation in PREDICT
Gueorguieva R, Wu R, O'Connor PG, Weisner C, Fucito LM, Hoffmann S, Mann K, O'Malley SS. Predictors of Abstinence from Heavy Drinking During Treatment in COMBINE and External Validation in PREDICT. Alcohol Clinical And Experimental Research 2014, 38: 2647-2656. PMID: 25346505, PMCID: PMC4397985, DOI: 10.1111/acer.12541.Peer-Reviewed Original ResearchAcamprosateAge FactorsAlcohol AbstinenceAlcohol DeterrentsAlcohol DrinkingBehavior TherapyCombined Modality TherapyControlled Clinical Trials as TopicDecision TreesGamma-GlutamyltransferaseGermanyGoalsHumansLogistic ModelsMiddle AgedNaltrexonePredictive Value of TestsRandomized Controlled Trials as TopicReproducibility of ResultsTaurineTime FactorsTreatment OutcomeUnited StatesAddressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA, Networks W. Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 2014, 16: 909-914. PMID: 24919399, PMCID: PMC6281057, DOI: 10.1093/ntr/ntu087.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousGuidelines as TopicHealth PolicyNicotineNonprescription DrugsRandomized Controlled Trials as TopicSmokingSmoking CessationTobacco Use Cessation DevicesUnited StatesUnited States Food and Drug AdministrationConceptsQuit attemptsQuit dateSmoking reductionEffective smoking cessation interventionsSubstantial public health burdenAid smoking cessationNicotine patch useSmoking cessation interventionPublic health burdenShort-acting formsNRT formulationsNRT medicationsRecalcitrant smokersNicotine patchCessation interventionsCigarette smokingSmoking cessationHealth burdenProvider consultationTobacco useDrug AdministrationRelapse preventionSmokersLabeling changesMonths